Supercritical assisted atomization (SAA) has been applied to the production of coprecipitates formed by hydroxyapatite nanometric particles and chitosan, used as binding agent.Precipitation temperatures between 90. ��C and 110. ��C have been used and a chitosan concentration lower than 20. mg/mL has been required to avoid microparticle coalescence. Furthermore, to obtain a good compromise between particle size and hydroxyapatite loading, a gas to liquid ratio of 1.8 was adopted. The best operating conditions for particle diameter and coprecipitate stability were: precipitation temperature 110. ��C, chitosan concentration in the starting solution 10. mg/mL, that produced spherical composite microparticles with a mean diameter of 0.6. ��m and a loading efficiency of about 91%. The nanostructure and particle surface roughness has been modulated varying hydroxyapatite percentages in the starting suspension. The results obtained have been explained in terms of suspension stabilization and atomization efficiency. Possible biomedical applications for these powders are described. �� 2013 Elsevier B.V.

Supercritical assisted atomization to produce nanostructured chitosan-hydroxyapatite microparticles for biomedical application

REVERCHON, Ernesto;ADAMI, RENATA
2013

Abstract

Supercritical assisted atomization (SAA) has been applied to the production of coprecipitates formed by hydroxyapatite nanometric particles and chitosan, used as binding agent.Precipitation temperatures between 90. ��C and 110. ��C have been used and a chitosan concentration lower than 20. mg/mL has been required to avoid microparticle coalescence. Furthermore, to obtain a good compromise between particle size and hydroxyapatite loading, a gas to liquid ratio of 1.8 was adopted. The best operating conditions for particle diameter and coprecipitate stability were: precipitation temperature 110. ��C, chitosan concentration in the starting solution 10. mg/mL, that produced spherical composite microparticles with a mean diameter of 0.6. ��m and a loading efficiency of about 91%. The nanostructure and particle surface roughness has been modulated varying hydroxyapatite percentages in the starting suspension. The results obtained have been explained in terms of suspension stabilization and atomization efficiency. Possible biomedical applications for these powders are described. �� 2013 Elsevier B.V.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11386/4255274
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 23
social impact